GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: ZE46-0134
Compound class:
Synthetic organic
Comment: Lomonitinib is the INN for a tyrosine kinase inhibitor with antineoplastic potential. It appears to be the INN for Eilean Therapeutics' pan-FLT3/IRAK4 inhibitor (ZE46-0134) that is designed to simultaneously target clinically relevant resistance and activating FLT3 mutations and putative escape pathways (that arise via activation of IRAK4) in advanced AML [1].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| 3-(3,4-dimethoxyphenyl)-1-(1,2,3,4-tetrahydroisoquinolin-7-yl)pyrazolo[4,3-c]quinoline |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 13355 | lomonitinib |
Synonyms ![]() |
| ZE46-0134 |
Database Links ![]() |
|
| CAS Registry No. | 2923221-56-9 (source: WHO INN record) |
| GtoPdb PubChem SID | 507750383 |
| PubChem CID | 171775678 |
| Search Google for chemical match using the InChIKey | AAIAGDXMETYTJE-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | AAIAGDXMETYTJE |
| Search PubMed clinical trials | lomonitinib |
| Search PubMed titles | lomonitinib |
| Search PubMed titles/abstracts | lomonitinib |
| UniChem Compound Search for chemical match using the InChIKey | AAIAGDXMETYTJE-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | AAIAGDXMETYTJE-UHFFFAOYSA-N |